These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity. Boonyasuppayakorn S; Reichert ED; Manzano M; Nagarajan K; Padmanabhan R Antiviral Res; 2014 Jun; 106():125-34. PubMed ID: 24680954 [TBL] [Abstract][Full Text] [Related]
4. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor. Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623 [TBL] [Abstract][Full Text] [Related]
5. Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action. Selaković Ž; Tran JP; Kota KP; Lazić M; Retterer C; Besch R; Panchal RG; Soloveva V; Sean VA; Jay WB; Pavić A; Verbić T; Vasiljević B; Kuehl K; Duplantier AJ; Bavari S; Mudhasani R; Šolaja BA Eur J Med Chem; 2019 Jan; 162():32-50. PubMed ID: 30408747 [TBL] [Abstract][Full Text] [Related]
6. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus. Cui Q; Cheng H; Xiong R; Zhang G; Du R; Anantpadma M; Davey RA; Rong L Viruses; 2018 Nov; 10(12):. PubMed ID: 30513600 [TBL] [Abstract][Full Text] [Related]
7. Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor. Cui Q; Du R; Anantpadma M; Schafer A; Hou L; Tian J; Davey RA; Cheng H; Rong L Viruses; 2018 Mar; 10(4):. PubMed ID: 29584652 [TBL] [Abstract][Full Text] [Related]
8. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses. Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic Prioritization of Diphyllin Derivatives That Block Filoviral Cell Entry by Vacuolar (H Lindstrom A; Anantpadma M; Baker L; Raghavendra NM; Davey R; Davisson VJ ChemMedChem; 2018 Dec; 13(24):2664-2676. PubMed ID: 30335906 [TBL] [Abstract][Full Text] [Related]
10. Development of therapeutics for treatment of Ebola virus infection. Li H; Ying T; Yu F; Lu L; Jiang S Microbes Infect; 2015 Feb; 17(2):109-17. PubMed ID: 25498866 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimalarial activity of new amino analogues of amodiaquine. Paunescu E; Susplugas S; Boll E; Varga RA; Mouray E; Grellier P; Melnyk P Med Chem; 2008 Sep; 4(5):407-25. PubMed ID: 18782038 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimalarial activity of new analogues of amodiaquine. Delarue-Cochin S; Paunescu E; Maes L; Mouray E; Sergheraert C; Grellier P; Melnyk P Eur J Med Chem; 2008 Feb; 43(2):252-60. PubMed ID: 17485145 [TBL] [Abstract][Full Text] [Related]
13. Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures. Dyall J; Nelson EA; DeWald LE; Guha R; Hart BJ; Zhou H; Postnikova E; Logue J; Vargas WM; Gross R; Michelotti J; Deiuliis N; Bennett RS; Crozier I; Holbrook MR; Morris PJ; Klumpp-Thomas C; McKnight C; Mierzwa T; Shinn P; Glass PJ; Johansen LM; Jahrling PB; Hensley LE; Olinger GG; Thomas C; White JM J Infect Dis; 2018 Nov; 218(suppl_5):S672-S678. PubMed ID: 29939303 [TBL] [Abstract][Full Text] [Related]